Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
2.
J Vet Pharmacol Ther ; 28(1): 21-7, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15720511

ABSTRACT

We recently described the clinical presentation and treatment of 18 elephants from six herds infected with TB. Treatment protocols and methods varied between herds to include both oral and rectal dosing using multiple drug doses and formulations. In this paper we present information regarding the pharmacokinetics (PK) of isoniazid (INH) in elephants and provide suggestions regarding initial treatment regimens. Forty-one elephants received INH daily by either oral or rectal administration with different formulations. Population PK analysis was performed using Non-linear Mixed Effect Modeling (NONMEM). Results of oral administration indicated that compared with premixed INH solution, the drug exposure was highest with a suspension prepared freshly with INH powder. When INH was concomitantly given as an admixture over food, Tmax was delayed and variability in drug absorption was significantly increased. Compared with oral administration, similar drug exposures were found when INH was dosed rectally. The data generated suggest that a starting dose of 7.5 mg/kg of INH is appropriate for initial TB treatment in elephants when premixed solution is administered directly into the oropharynx or rectal vault and 4 mg/kg are when INH is administered following immediate suspension from powdered form.


Subject(s)
Antitubercular Agents/pharmacokinetics , Elephants/metabolism , Isoniazid/pharmacokinetics , Administration, Oral , Administration, Rectal , Animals , Antitubercular Agents/administration & dosage , Antitubercular Agents/blood , Antitubercular Agents/therapeutic use , Area Under Curve , Female , Isoniazid/administration & dosage , Isoniazid/blood , Isoniazid/therapeutic use , Male , Mycobacterium tuberculosis , Tuberculosis/drug therapy , Tuberculosis/veterinary
3.
J Zoo Wildl Med ; 32(1): 1-16, 2001 Mar.
Article in English | MEDLINE | ID: mdl-12790389

ABSTRACT

The deaths of two Asian elephants (Elephas maximus) in August 1996 led the United States Department of Agriculture to require the testing and treatment of elephants for tuberculosis. From August 1996 to September 1999. Mycobacterium tuberculosis infection was confirmed by culture in 12 of 118 elephants in six herds. Eight diagnoses were made antemortem on the basis of isolation of M. tuberculosis by culture of trunk wash samples; the remainder (including the initial two) were diagnosed postmortem. We present the case histories, epidemiologic characteristics, diagnostic test results, and therapeutic plans from these six herds. The intradermal tuberculin test, enzyme-linked immunosorbent assay serology, the blood tuberculosis test, and nucleic acid amplification and culture are compared as methods to diagnose M. tuberculosis infection in elephants.


Subject(s)
Elephants , Mycobacterium tuberculosis/isolation & purification , Tuberculosis/veterinary , Animals , Animals, Wild , Antibodies, Bacterial/blood , Enzyme-Linked Immunosorbent Assay/veterinary , Female , Male , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/immunology , Nasal Mucosa/microbiology , Nucleic Acid Amplification Techniques/veterinary , Tuberculin Test/veterinary , Tuberculosis/diagnosis , Tuberculosis/epidemiology , United States/epidemiology
4.
Bioseparation ; 8(1-5): 209-17, 1999.
Article in English | MEDLINE | ID: mdl-10734573

ABSTRACT

We describe a process for the commercial manufacture of therapeutic grade plasmid DNA. The industrially scaleable unit operations employed in this process are: (i) optimized alkaline lysis; (ii) bag filtration; (iii) expanded bed anion exchange chromatography; (iv) ultrafiltration, and (v) size exclusion chromatography. These steps are scaleable alternatives to current approaches to plasmid DNA isolation such as high speed centrifugation for feed-stock clarification and solvent precipitation for plasmid concentration, and an efficient alternative to conventional low through-put packed bed chromatography. The process produces plasmid DNA characterized by low level chromosomal DNA, RNA and endotoxin contamination without the use of flammable solvents or toxic reagents and is suitable for therapeutic administration.


Subject(s)
Chromatography, Gel/methods , Chromatography, Ion Exchange/methods , DNA, Recombinant/genetics , Genetic Therapy , Plasmids , Anion Exchange Resins , DNA, Recombinant/therapeutic use , Electrophoresis, Agar Gel , Humans , Hydrogen-Ion Concentration
SELECTION OF CITATIONS
SEARCH DETAIL
...